🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

IBD kliniek Bonheiden contributed to this largest cohort of patients with #IBD on biological and/or small molecule combination therapy: combination is possible but 🚨 opportunistic infections leading to 🏥 Bird Group onlinelibrary.wiley.com/doi/10.1002/ue…

11 presentations from IBD kliniek Bonheiden collaborative work #ECCO2022. Thanks to all #IBDnurses and studycoordinators 👇 OP01, OP03, OP28, OP40 DOP44, DOP82 N01 P260, P522, P544, P576 Bird Group CHU de Liège UZ Gent IBD Leuven TARGID KU LEUVEN #upadacitinib #risankizumab #ozanimod

A cure for #IBD might seem not achievable, but this was the case for the #missiontothemoon 100 years ago. #ECCO2022 🔟 gaps to close #Microbiome #Genetics #Nutrition #Disease phenotype #Predictive biomarkers #Early diagnosis #Endoscopic scoring #Fatigue #Q o care #Study design

collaborative #nursepower !

Clara Caenepeel presenting data on the #RESTORE #FMT in #UC, a sham-controlled multicenter Belgian RCT Severine Vermeire João Sabino Bram Verstockt IBD kliniek Bonheiden. Thanks to all collaborative Belgian centers and patients!

OP03 @ #ECCO2022 RESTORE-UC study RCT autologuous FMT vs Superdonor FMT highly standardized prep protocol ➡️prematurely stopped at interim futility analysis back to the bench to explore negative results (genetics, receptor) IBD kliniek Bonheiden IBD Leuven

(too?) optimistic proactive TDM part 2 nice study but 🚨 conclusion NOR-DRUM B #ECCO2022 -open label -no objective markers (PRO + patient-physician consensus) -small numbers -similar TL @ibdkliniek provides just the opposite (too?) negative conclusion academic.oup.com/ecco-jcc/advan…

Highly recommended presentation by Peter Bossuyt

Collaborative work from Bird Group and UZ Gent on a very relevant and difficult problem in #IBD #fatigue in patients in remission 🚨no effect in this blinded randomized cross over study. #ECCO2022

In the last oral abstract of #ECCO2022, Peter Bossuyt Peter Bossuyt examines the effect of baseline #Crohn's disease location on the efficacy of risankizumab induction and maintenance therapy #GITwitter #IBD

Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial academic.oup.com/ecco-jcc/artic…

Full house voor de 13e patiëntendag van IBD kliniek Bonheiden. Mooie voordrachten van #drPouillon #drDufraimont en Peter Bossuyt. Dank aan @ccv_vzw om dit mee te organiseren.

Vandaag is het #woldIBDday! De ziekte van #Crohn en #colitis ulcerosa blijven vaak verborgen aandoeningen, maar kunnen een belangrijk #impact hebben op sociaal leven, werk en relatie. Daarom willen we onze patiënten met #IBD in de picture zetten. #Awareness #purpleribbon

Nice way to end the week as co-author of two papers in the latest issue of The Lancet Joint effort of the full IBD kliniek Bonheiden team! #risankizumab as induction and maintenance treatment for patients with #crohnsdisease thelancet.com/journals/lance…

Looking forward to starting the moderated poster session with IBD kliniek Bonheiden my_UEG #UEGW2022

linkedin.com/posts/activity…

My last meeting with the #ECCO ClinCom. After 4 years, looking back to multiple workshops and efforts to boost collaborative research in Europe. Happy to pass my position to Tanja Kuehbacher and Murat Toruner. #ecco23

Full house for our annual #patient day of IBD kliniek Bonheiden Action pays off! 3 tools for self management of #IBD - Active life style for fatigue - Know your diet - Smoking cessation IBD kliniek Bonheiden can help you with tailored revalidation, diet advice and smoking cessation programs.

Since 2019, research led by VIB-KU Leuven Center for Microbiology, UZ Leuven and IBD kliniek Bonheiden has aimed to tackle Inflammatory Bowel Disease (IBD) using our own gut microbiome 🤝. Read the blog and discover the successes and challenges of this research project! #VIBmicrobes ➡️ vibbio.tech/3Q2B7CG

Thank you and goodbye. We leave twitter. #maketheworldgreatagain